195 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Bought by E Fund Management Hong Kong Co. Ltd.

by · The Cerbat Gem

E Fund Management Hong Kong Co. Ltd. purchased a new position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 195 shares of the biotechnology company’s stock, valued at approximately $78,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brookstone Capital Management lifted its position in Axon Enterprise by 5.1% during the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after buying an additional 41 shares during the period. Wealth Enhancement Advisory Services LLC lifted its position in Axon Enterprise by 4.4% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 7,519 shares of the biotechnology company’s stock valued at $2,353,000 after buying an additional 319 shares during the period. Hennion & Walsh Asset Management Inc. purchased a new position in Axon Enterprise during the first quarter valued at $392,000. Diversified Trust Co lifted its position in Axon Enterprise by 61.3% during the first quarter. Diversified Trust Co now owns 2,140 shares of the biotechnology company’s stock valued at $670,000 after buying an additional 813 shares during the period. Finally, Sumitomo Mitsui Trust Holdings Inc. lifted its position in Axon Enterprise by 14.8% during the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 170,376 shares of the biotechnology company’s stock valued at $53,307,000 after buying an additional 22,013 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Robert W. Baird raised their price objective on Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a research report on Tuesday, September 10th. JMP Securities raised their price target on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, September 12th. Craig Hallum raised their price target on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Northland Securities raised their price target on Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a report on Thursday, August 8th. Finally, The Goldman Sachs Group raised their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $382.85.

Get Our Latest Analysis on Axon Enterprise

Axon Enterprise Stock Down 1.1 %

NASDAQ AXON opened at $439.00 on Thursday. The stock’s 50 day moving average is $400.22 and its 200 day moving average is $339.14. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 12 month low of $199.50 and a 12 month high of $455.17. The stock has a market cap of $33.13 billion, a PE ratio of 128.36, a P/E/G ratio of 11.91 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The company had revenue of $504.00 million for the quarter, compared to analysts’ expectations of $478.35 million. During the same period in the previous year, the firm earned $0.80 EPS. The firm’s revenue was up 34.5% compared to the same quarter last year. Research analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the transaction, the director now directly owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Axon Enterprise news, CEO Patrick W. Smith sold 4,767 shares of Axon Enterprise stock in a transaction that occurred on Thursday, October 3rd. The stock was sold at an average price of $404.14, for a total value of $1,926,535.38. Following the sale, the chief executive officer now owns 2,925,060 shares of the company’s stock, valued at $1,182,133,748.40. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now directly owns 26,259 shares in the company, valued at approximately $11,500,916.82. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 371,172 shares of company stock valued at $137,000,162. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).